BEST PRACTICE ANTICOAGULATION PROCESS FOR DEEP VEIN THROMBOSIS THERAPY REDUCE ADMISSIONS
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Poster
- Poster code: POS-HPS-056
- By: JENSEN, Melanie (Advent Health, United States)
- Co-author(s): Melanie Jensen: Pharmacy, Advent Health, Orlando, United States
Oscar Santalo: Pharmacy, Advent Health, Orlando, United States - Abstract:
Background
For deep vein thrombosis (DVT), the average length of stay (LOS) is 5.8 days and the mean acute-care hospital costs are $5,779 per visit. Early-directed protocols with a direct oral anticoagulant (DOAC) for DVT management for early discharge have been shown to prevent patient admissions, improve patient follow-up, and decrease hospital.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023